Amicus Therapeutics (FOLD) Lower; Sanofi's Fabry Disease Treatment Receives Orphan Designation
Tweet Send to a Friend
Amicus Therapeutics (NASDAQ: FOLD) shares are slipping lower Friday on news that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
